These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7684432)

  • 21. The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells.
    Thanhäuser A; Böhle A; Schneider B; Reiling N; Mattern T; Ernst M; Flad HD; Ulmer AJ
    Cancer Immunol Immunother; 1995 Feb; 40(2):103-8. PubMed ID: 7882379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin.
    Worku S; Hoft DF
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S257-61. PubMed ID: 10875795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin.
    Molloy A; Laochumroonvorapong P; Kaplan G
    J Exp Med; 1994 Oct; 180(4):1499-509. PubMed ID: 7931080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals.
    Gryllis C; Wainberg MA; Bentwich Z; Gornitsky M; Brenner BG
    Clin Exp Immunol; 1992 Sep; 89(3):356-61. PubMed ID: 1381298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.
    Rahman MU; Mazumder A
    J Clin Immunol; 1992 Jul; 12(4):281-8. PubMed ID: 1355096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages.
    Endsley JJ; Endsley MA; Estes DM
    J Leukoc Biol; 2006 Jan; 79(1):71-9. PubMed ID: 16275895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysis of human macrophages by cytolytic CD4+ T cells fails to affect survival of intracellular Mycobacterium bovis-bacille Calmette-Guérin (BCG).
    Fazal N; Lammas DA; Rahelu M; Pithie AD; Gaston JS; Kumararatne DS
    Clin Exp Immunol; 1995 Jan; 99(1):82-9. PubMed ID: 7813114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype.
    Derby E; Reddy V; Baseler M; Malyguine A
    Biotechniques; 2001 Sep; 31(3):660, 664-5. PubMed ID: 11570508
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies.
    Higuchi CM; Thompson JA; Cox T; Lindgren CG; Buckner CD; Fefer A
    Cancer Res; 1989 Oct; 49(20):5509-13. PubMed ID: 2477142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
    Marras F; Bozzano F; Bentivoglio G; Ugolotti E; Biassoni R; Moretta L; De Maria A
    Eur J Immunol; 2012 Sep; 42(9):2459-70. PubMed ID: 22736333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypical study of human lymphokine-activated killer (LAK) cells.
    Barral AM; García CA
    Neoplasma; 1989; 36(5):583-8. PubMed ID: 2682296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
    Valentin H; Groux H; Gelin C; Chretien I; Bernard A
    J Immunol; 1990 Feb; 144(3):875-82. PubMed ID: 1967277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of lymphokine-activated killer cells to lyse mycobacteria-infected cells.
    Chiplunkar SV; Deshmukh MA; Kode JA; Gangal SG; Deo MG
    Acta Leprol; 1997; 10(4):203-8. PubMed ID: 9447253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human monocytes inhibit lymphokine-activated killer cell expansion in vitro.
    Triozzi PL; Aldrich WA; Rinehart JJ
    Mol Biother; 1991 Mar; 3(1):22-5. PubMed ID: 2069757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.
    Thanhäuser A; Reiling N; Böhle A; Toellner KM; Duchrow M; Scheel D; Schlüter C; Ernst M; Flad HD; Ulmer AJ
    Immunology; 1993 Sep; 80(1):151-6. PubMed ID: 8244458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
    Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.